|
XLO
|
Xilio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
XLV
|
SPDR Select Sector Fund - Health Care
|
US
|
AMEX
|
|
XNCR
|
Xencor, Inc.
|
US
|
NASDAQ
|
|
XTLB
|
XTL Biopharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
XXII
|
22nd Century Group, Inc.
|
US
|
NASDAQ
|
|
ZY
|
Zymergen Inc.
|
US
|
NASDAQ
|
|
ACW
|
Actinogen Medical Ltd
|
AU
|
ASX
|
|
ALA
|
Arovella Therapeutics Limited
|
AU
|
ASX
|
|
ANR
|
Anatara Lifesciences Ltd
|
AU
|
ASX
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
AVE
|
Avecho Biotechnology Limited
|
AU
|
ASX
|
|
BDX
|
BCAL Diagnostics Ltd
|
AU
|
ASX
|
|
BGT
|
Bio-Gene Technology Ltd
|
AU
|
ASX
|
|
BIT
|
Biotron Limited
|
AU
|
ASX
|
|
BPH
|
BPH Energy Ltd
|
AU
|
ASX
|
|
BTC
|
BioTech Capital Limited
|
AU
|
ASX
|
|
CGS
|
CogState Limited
|
AU
|
ASX
|
|
CHM
|
Chimeric Therapeutics Limited NL
|
AU
|
ASX
|
|
CIN
|
Carlton Investments Limited
|
AU
|
ASX
|
|
COH
|
Cochlear Limited
|
AU
|
ASX
|